As of August 2026, 39 paid clinical trials are recruiting in West Reading, Pennsylvania. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
West Reading offers studies at sites including Reading Hospital for conditions such as Acute Myeloid Leukemia, Anatomic Stage II Breast Cancer AJCC v8, Stage IIIB Lung Cancer AJCC v8, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Researchers run research studies in West Reading, PA at 8 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Reading Hospital | Acute Myeloid Leukemia, Anatomic Stage II Breast Cancer AJCC v8, Stage IIIB Lung Cancer AJCC v8 | 29 |
| McGlinn Cancer Institute | B Cell Lymphoma, HR+/HER2- Breast Cancer, Mantle Cell Lymphoma | 2 |
| Reading Hospital - McGlinn Cancer Institute | KRAS G12C Lung Cancer, Non-Small Cell Lung Cancer, Refractory Diffuse Large B-cell Lymphoma | 2 |
| Cardiology Associates of West Reading | Percutaneous Coronary Intervention, Peripheral Endovascular Intervention | 1 |
| McGlinn Cancer Institute Reading Hospital | Carcinoma, Non-Small-Cell Lung | 1 |
| Reading Health System | Prostate Cancer | 1 |
| Reading Hospital, an affiliate of Tower Health | Diabetes Education, Diabetes Mellitus, Type 2, Lifestyle Modification | 1 |
| Tower Health Reading Hospital | Abdominal Wound Dehiscence, Anal Fistula, Hidradenitis Suppurativa | 1 |
Recruiting trials in West Reading grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
There are approximately 39 recruiting clinical trials in West Reading, Pennsylvania listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in West Reading compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in West Reading include Acute Myeloid Leukemia (5), Anatomic Stage II Breast Cancer AJCC v8 (3), Stage IIIB Lung Cancer AJCC v8 (3), Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm (2), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in West Reading on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in West Reading include Reading Hospital, McGlinn Cancer Institute, Reading Hospital - McGlinn Cancer Institute, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in West Reading are Cancer & tumors (31), Cardiovascular (3), Mental health & behavior (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.